LTG-001, a selective inhibitor for treatment of acute pain, was granted Fast Track designation by the Food and Drug Administration (FDA).
In two randomized clinical trials evaluating pain control following abdominoplasty and bunionectomy, Journavx demonstrated ...
In my years as a nurse working in a drug detox unit, I’ve witnessed both the crushing grip of addiction and the grueling ...
Guilford County and local governments across the state are doing what they can to help substance abusers kick the habit – ...
1d
Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) TD Cowen 45th Annual Health Care Conference Transcript March 3, 2025 3:10 PM ET David Altshuler - Executive Vice President, Global Research and CSO ...
GlobalData on MSN1d
Lexicon’s non-opioid therapy for DPNP beats placebo in pain reductionThe company has chosen to move ahead to Phase III trials with its 10mg dose after it saw a 1.74-point reduction in pain score ...
Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...
Lexicon Pharmaceuticals is yet again defending a mixed set of data on its non-opioid pain prospect. | Lexicon Pharmaceuticals ...
Mexico has handled the cartels so poorly that it broke international law. It is obligated to prevent the harm cartels are ...
These books reveal how power, inequality, and misinformation shape today’s world, explaining why modern society feels ...
We recently compiled a list of the 12 Best Small Cap Pharma Stocks to Buy Now. In this article, we are going to take a look ...
Sen. Mark Kelly champions the PAIN Act to improve seniors' access to non-opioid pain treatments under Medicare.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback